HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Announces More Layoffs, Plans To Exit Ireland

This article was originally published in The Rose Sheet

Executive Summary

As part of Avon Products Inc.’s previously announced $400 million Cost Saving Initiative, the firm has announced plans to exit Ireland and eliminate 400 positions globally, among other measures.

You may also be interested in...



Analysts On Avon Buyout Rumor: Easier Turnaround ‘Outside The Public Eye’?

Morningstar analyst Eric Lash speculates that the “drastic actions necessary to right Avon’s ship” may be more easily implemented if private equity firm TPG Capital added the direct seller to its portfolio, which already includes Avon Japan. The investment community weighs in on an unconfirmed report that Avon is exploring a potential buyout.

Scrutiny Of Direct Selling Businesses Prompts Avon To Leave Trade Group

Avon says its own policies provide better protections to sales representatives than U.S. DSA’s code of ethics. DSA efforts to refute pyramid scheme allegations against some direct sellers help “a few specific brands” at the expense of the rest of the industry, the firm contends.

Scrutiny Of Direct Selling Businesses Prompts Avon To Leave Trade Group

Avon says its own policies provide better protections to sales representatives than U.S. DSA’s code of ethics. DSA efforts to refute pyramid scheme allegations against some direct sellers help “a few specific brands” at the expense of the rest of the industry, the firm contends.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel